432 related articles for article (PubMed ID: 24124328)
1. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
Tack GJ; van de Water JM; Bruins MJ; Kooy-Winkelaar EM; van Bergen J; Bonnet P; Vreugdenhil AC; Korponay-Szabo I; Edens L; von Blomberg BM; Schreurs MW; Mulder CJ; Koning F
World J Gastroenterol; 2013 Sep; 19(35):5837-47. PubMed ID: 24124328
[TBL] [Abstract][Full Text] [Related]
2. Effect of
Stefanolo JP; Segura V; Grizzuti M; Heredia A; Comino I; Costa AF; Puebla R; Temprano MP; Niveloni SI; de Diego G; Oregui ME; Smecuol EG; de Marzi MC; Verdú EF; Sousa C; Bai JC
World J Gastroenterol; 2024 Mar; 30(11):1545-1555. PubMed ID: 38617446
[TBL] [Abstract][Full Text] [Related]
3. Glutenase ALV003 attenuates gluten-induced mucosal injury in patients with celiac disease.
Lähdeaho ML; Kaukinen K; Laurila K; Vuotikka P; Koivurova OP; Kärjä-Lahdensuu T; Marcantonio A; Adelman DC; Mäki M
Gastroenterology; 2014 Jun; 146(7):1649-58. PubMed ID: 24583059
[TBL] [Abstract][Full Text] [Related]
4. Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
Goel G; King T; Daveson AJ; Andrews JM; Krishnarajah J; Krause R; Brown GJE; Fogel R; Barish CF; Epstein R; Kinney TP; Miner PB; Tye-Din JA; Girardin A; Taavela J; Popp A; Sidney J; Mäki M; Goldstein KE; Griffin PH; Wang S; Dzuris JL; Williams LJ; Sette A; Xavier RJ; Sollid LM; Jabri B; Anderson RP
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):479-493. PubMed ID: 28506538
[TBL] [Abstract][Full Text] [Related]
5. Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation.
Montserrat V; Bruins MJ; Edens L; Koning F
Food Chem; 2015 May; 174():440-5. PubMed ID: 25529703
[TBL] [Abstract][Full Text] [Related]
6. Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
Silvester JA; Kurada S; Szwajcer A; Kelly CP; Leffler DA; Duerksen DR
Gastroenterology; 2017 Sep; 153(3):689-701.e1. PubMed ID: 28545781
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
Lähdeaho ML; Scheinin M; Vuotikka P; Taavela J; Popp A; Laukkarinen J; Koffert J; Koivurova OP; Pesu M; Kivelä L; Lovró Z; Keisala J; Isola J; Parnes JR; Leon F; Mäki M
Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):948-959. PubMed ID: 31494096
[TBL] [Abstract][Full Text] [Related]
8. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
[TBL] [Abstract][Full Text] [Related]
9. Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting.
König J; Holster S; Bruins MJ; Brummer RJ
Sci Rep; 2017 Oct; 7(1):13100. PubMed ID: 29026170
[TBL] [Abstract][Full Text] [Related]
10. Poor Sensitivity of Fecal Gluten Immunogenic Peptides and Serum Antibodies to Detect Duodenal Mucosal Damage in Celiac Disease Monitoring.
Laserna-Mendieta EJ; Casanova MJ; Arias Á; Arias-González L; Majano P; Mate LA; Gordillo-Vélez CH; Jiménez M; Angueira T; Tébar-Romero E; Carrillo-Ramos MJ; Tejero-Bustos MÁ; Gisbert JP; Santander C; Lucendo AJ
Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396719
[TBL] [Abstract][Full Text] [Related]
11. Negative predictive value of the repeated absence of gluten immunogenic peptides in the urine of treated celiac patients in predicting mucosal healing: new proposals for follow-up in celiac disease.
Ruiz-Carnicer Á; Garzón-Benavides M; Fombuena B; Segura V; García-Fernández F; Sobrino-Rodríguez S; Gómez-Izquierdo L; Montes-Cano MA; Rodríguez-Herrera A; Millán R; Rico MC; González-Naranjo C; Bozada-García JM; Díaz J; Coronel-Rodríguez C; Espín B; Romero-Gómez M; Cebolla Á; Sousa C; Comino I; Argüelles F; Pizarro Á
Am J Clin Nutr; 2020 Nov; 112(5):1240-1251. PubMed ID: 32692806
[TBL] [Abstract][Full Text] [Related]
12. A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet.
Rees D; Holtrop G; Chope G; Moar KM; Cruickshank M; Hoggard N
Br J Nutr; 2018 Mar; 119(5):496-506. PubMed ID: 29508689
[TBL] [Abstract][Full Text] [Related]
13. No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease.
Murray JA; Kelly CP; Green PHR; Marcantonio A; Wu TT; Mäki M; Adelman DC;
Gastroenterology; 2017 Mar; 152(4):787-798.e2. PubMed ID: 27864127
[TBL] [Abstract][Full Text] [Related]
14. Randomised clinical study: Aspergillus niger-derived enzyme digests gluten in the stomach of healthy volunteers.
Salden BN; Monserrat V; Troost FJ; Bruins MJ; Edens L; Bartholomé R; Haenen GR; Winkens B; Koning F; Masclee AA
Aliment Pharmacol Ther; 2015 Aug; 42(3):273-85. PubMed ID: 26040627
[TBL] [Abstract][Full Text] [Related]
15. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.
Mitea C; Havenaar R; Drijfhout JW; Edens L; Dekking L; Koning F
Gut; 2008 Jan; 57(1):25-32. PubMed ID: 17494108
[TBL] [Abstract][Full Text] [Related]
16. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge.
Dotsenko V; Oittinen M; Taavela J; Popp A; Peräaho M; Staff S; Sarin J; Leon F; Isola J; Mäki M; Viiri K
Cell Mol Gastroenterol Hepatol; 2021; 11(1):13-32. PubMed ID: 32745639
[TBL] [Abstract][Full Text] [Related]
17. Serum transglutaminase antibodies do not always detect the persistent villous atrophy in patients with celiac disease on a gluten-free diet.
Stefanelli G; Navisse S; Valvano M; Vernia F; Ciccone A; Melideo D; Necozione S; Calvisi G; Coletti G; Viscido A; Latella G
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e650-e655. PubMed ID: 34034270
[TBL] [Abstract][Full Text] [Related]
18. Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease.
Vahedi K; Mascart F; Mary JY; Laberenne JE; Bouhnik Y; Morin MC; Ocmant A; Velly C; Colombel JF; Matuchansky C
Am J Gastroenterol; 2003 May; 98(5):1079-87. PubMed ID: 12809831
[TBL] [Abstract][Full Text] [Related]
19. Production of the prolyl endoprotease (PEP) from Aspergillus sp. FSDE 16 by solid-state fermentation (SSF) and use for producing a gluten-free beer.
Almeida TC; Santos SFM; Santos ESD
Biotechnol Appl Biochem; 2024 Apr; 71(2):460-476. PubMed ID: 38212282
[TBL] [Abstract][Full Text] [Related]
20. Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.
Moreno ML; Cebolla Á; Muñoz-Suano A; Carrillo-Carrion C; Comino I; Pizarro Á; León F; Rodríguez-Herrera A; Sousa C
Gut; 2017 Feb; 66(2):250-257. PubMed ID: 26608460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
